HYPMY
Hypera S.A.
Price Chart
Latest Quote
$4.15
+0.05 (+1.22%)
Current Price
| Previous Close | $4.10 |
| Open | $4.00 |
| Day High | $4.15 |
| Day Low | $4.00 |
| Volume | 14,873 |
Stock Information
Note: Financial values converted from BRL to USD
| Quarterly Dividend / Yield | $0.21 / 5.12% |
| Shares Outstanding | 703.99M |
| Quarterly Dividend Yield | 5.12% |
| Quarterly Dividend | $0.21 |
| Total Debt | $1.69B |
| Cash Equivalents | $445.46M |
| Revenue | $1.66B |
| Net Income | $323.83M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $2.92B |
| P/E Ratio | 8.14 |
| EPS (TTM) | $0.51 |
| Exchange | OID |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $9.40B |
| Sales | $1.66B |
| Income | $323.83M |
| Book/sh | $3.92 |
| Cash/sh | $3.28 |
| Employees | 11K |
Financial Ratios
| Quick Ratio | 1.29 |
| Current Ratio | 1.96 |
| Debt/Eq | 62.25 |
Returns & Margins
| ROA | 6.16% |
| ROE | 12.95% |
| Gross Margin | 60.74% |
| Operating Margin | 25.25% |
| Profit Margin | 19.49% |
Ownership
| Institutional Ownership | 0.00% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 0.34 |
| P/B | 1.06 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $4.14 |
| SMA50 | $4.44 |
| SMA200 | $4.36 |
| RSI | 47.65 |
| ATR | 0.1443 |
| Shares Float | 304.92M |
| Volatility | 0.09 |
| Rel Volume | 2.48 |
Performance History
| Week | +2.72% |
| Month | -5.90% |
| Quarter | -6.93% |
| 6 Months | -3.40% |
| YTD | -1.61% |
| Year | -6.38% |
| 3 Years | -49.81% |
| 5 Years | -29.87% |
| 10 Years | -25.38% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $4.15 | 62,400 |
| 2026-06-23 | $4.10 | 57,200 |
| 2026-06-22 | $3.91 | 17,000 |
| 2026-06-18 | $3.81 | 9,600 |
| 2026-06-17 | $3.97 | 3,700 |
| 2026-06-16 | $4.04 | 2,000 |
| 2026-06-15 | $4.20 | 5,300 |
| 2026-06-12 | $4.13 | 120,300 |
| 2026-06-11 | $4.04 | 10,100 |
| 2026-06-10 | $3.98 | 4,700 |
| 2026-06-09 | $4.08 | 7,800 |
| 2026-06-08 | $3.96 | 69,500 |
| 2026-06-05 | $4.20 | 3,900 |
| 2026-06-04 | $4.25 | 3,000 |
| 2026-06-03 | $4.22 | 3,600 |
| 2026-06-02 | $4.30 | 21,000 |
| 2026-06-01 | $4.30 | 26,100 |
| 2026-05-29 | $4.35 | 25,200 |
| 2026-05-28 | $4.40 | 26,700 |
| 2026-05-27 | $4.41 | 23,600 |
| 2026-05-26 | $4.39 | 28,600 |
About Hypera S.A.
Hypera S.A. operates as a pharmaceutical company in Brazil. The company provides sweeteners products under the Adocyl, finn, and Zero-cal brands; analgesics and anti-inflammatories products under the Doril, Atroveran, Calminex, Alivium, Buscopan, Buscofem, geloll, Torsilax, Neosaldina, and naprohax brands; cold and flu remedies and decongestants products under BENEGRIO, Rinosoro, Blu, Neosoro, Coristina, APRACUR, and Fluviral brands. It offers antihistamines products under Alektos, Histamin, Polaramine, PredSim, and Desrinite brands; antiseptics products under Merthiolate brand; Herbal medicine products under Maracugina, Eparema, Tamarine, and Naturetti brands; gastrointestinal products under Dramin, Estomazil, Engov, Lacto-purga, gastrol, Epocler, Bifilax, and Pepsamar brands. In addition, the company provides generics products under neo quimica brand; skicare products under episol, epidrat, simple organic, and bioage brands; supplements and vitamins products Addera, Biotonico Fontoura, Colflex, and Vitasay brands; and other products under Nebacetin, Cepacol, ESCABIN, Mirrorelax, Ammy, Nesina, and Diprospan brands. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. was founded in 1999 and is headquartered in SÃŖo Paulo, Brazil.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $3,061,467,000 | $2,919,114,000 | $2,784,831,000 | $2,134,487,000 |
| Cost Of Revenue | $3,061,467,000 | $2,919,114,000 | $2,784,831,000 | $2,134,487,000 |
| Total Revenue | $7,442,466,000 | $7,914,658,000 | $7,546,355,000 | $5,937,373,000 |
| Operating Revenue | $7,442,466,000 | $7,914,658,000 | $7,546,355,000 | $5,937,373,000 |
| Expenses | ||||
| Interest Expense | $971,047,000 | $1,129,149,000 | $986,082,000 | $383,218,000 |
| Total Expenses | $5,646,697,000 | $5,416,740,000 | $5,087,015,000 | $3,985,211,000 |
| Net Non Operating Interest Income Expense | $-1,043,615,000 | $-1,168,886,000 | $-1,006,373,000 | $-400,427,000 |
| Total Other Finance Cost | $107,715,000 | $98,455,000 | $91,138,000 | $53,143,000 |
| Interest Expense Non Operating | $971,047,000 | $1,129,149,000 | $986,082,000 | $383,218,000 |
| Operating Expense | $2,585,230,000 | $2,497,626,000 | $2,302,184,000 | $1,850,724,000 |
| Other Operating Expenses | $5,702,000 | $4,878,000 | $1,874,000 | $5,434,000 |
| Selling And Marketing Expense | $2,036,552,000 | $1,910,710,000 | $1,760,186,000 | $1,481,049,000 |
| General And Administrative Expense | $89,285,000 | $84,357,000 | $92,806,000 | $67,423,000 |
| Other Non Operating Income Expenses | - | - | $118,000 | $4,888,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $1,343,115,000 | $1,648,523,000 | $1,704,750,000 | $1,617,652,000 |
| Net Interest Income | $-1,043,615,000 | $-1,168,886,000 | $-1,006,373,000 | $-400,427,000 |
| Interest Income | $35,147,000 | $58,718,000 | $70,847,000 | $35,934,000 |
| Normalized Income | $1,365,246,780 | $1,667,225,420 | $1,747,471,120 | $1,625,522,500 |
| Net Income From Continuing And Discontinued Operation | $1,340,990,000 | $1,647,960,000 | $1,696,697,000 | $1,330,208,000 |
| Net Income Common Stockholders | $1,340,990,000 | $1,647,960,000 | $1,696,697,000 | $1,330,208,000 |
| Net Income | $1,340,990,000 | $1,647,960,000 | $1,696,697,000 | $1,330,208,000 |
| Net Income Including Noncontrolling Interests | $1,330,875,000 | $1,650,550,000 | $1,698,399,000 | $1,330,305,000 |
| Net Income Discontinuous Operations | $-2,125,000 | $-563,000 | $-8,053,000 | $-287,444,000 |
| Net Income Continuous Operations | $1,333,000,000 | $1,651,113,000 | $1,706,452,000 | $1,617,749,000 |
| Pretax Income | $979,238,000 | $1,509,475,000 | $1,611,104,000 | $1,644,329,000 |
| Interest Income Non Operating | $35,147,000 | $58,718,000 | $70,847,000 | $35,934,000 |
| Operating Income | $1,795,769,000 | $2,497,918,000 | $2,459,340,000 | $1,952,162,000 |
| Depreciation And Amortization In Income Statement | $174,629,000 | $151,811,000 | $100,815,000 | $74,507,000 |
| Depreciation Income Statement | $174,629,000 | $151,811,000 | $100,815,000 | $74,507,000 |
| Gross Profit | $4,380,999,000 | $4,995,544,000 | $4,761,524,000 | $3,802,886,000 |
| Per Share | ||||
| Diluted EPS | $2.10 | $2.58 | $2.65 | $2.08 |
| Basic EPS | $2.12 | $2.61 | $2.68 | $2.11 |
| Other | ||||
| Tax Effect Of Unusual Items | $-11,401,220 | $-9,634,580 | $-2,726,880 | $-874,500 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $2,264,873,000 | $2,905,273,000 | $2,811,735,000 | $2,169,978,000 |
| Total Unusual Items | $-33,533,000 | $-28,337,000 | $-45,448,000 | $-8,745,000 |
| Total Unusual Items Excluding Goodwill | $-33,533,000 | $-28,337,000 | $-45,448,000 | $-8,745,000 |
| Reconciled Depreciation | $281,055,000 | $238,312,000 | $169,101,000 | $133,686,000 |
| EBITDA (Bullshit earnings) | $2,231,340,000 | $2,876,936,000 | $2,766,287,000 | $2,161,233,000 |
| EBIT | $1,950,285,000 | $2,638,624,000 | $2,597,186,000 | $2,027,547,000 |
| Diluted Average Shares | $637,891,000 | $637,793,000 | $639,103,000 | $639,532,000 |
| Basic Average Shares | $632,708,000 | $632,460,000 | $632,211,000 | $631,969,000 |
| Diluted NI Availto Com Stockholders | $1,340,990,000 | $1,647,960,000 | $1,696,697,000 | $1,330,208,000 |
| Otherunder Preferred Stock Dividend | $0 | $0 | $0 | $0 |
| Minority Interests | $10,115,000 | $-2,590,000 | $-1,702,000 | $-97,000 |
| Tax Provision | $-353,762,000 | $-141,638,000 | $-95,348,000 | $26,580,000 |
| Research And Development | $145,526,000 | $169,506,000 | $159,391,000 | $126,693,000 |
| Selling General And Administration | $2,125,837,000 | $1,995,067,000 | $1,852,992,000 | $1,548,472,000 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $305,426,000 | $72,284,000 | $-449,712,000 | $-170,571,000 |
| Total Assets | $24,559,083,000 | $24,508,751,000 | $23,755,633,000 | $19,817,962,000 |
| Total Non Current Assets | $17,877,207,000 | $16,430,985,000 | $15,225,513,000 | $13,326,329,000 |
| Other Non Current Assets | $259,291,000 | $213,845,000 | $188,109,000 | $249,619,000 |
| Non Current Deferred Taxes Assets | $1,684,251,000 | $869,524,000 | $603,170,000 | $355,115,000 |
| Financial Assets | $33,995,000 | $11,848,000 | $24,125,000 | $0 |
| Goodwill And Other Intangible Assets | $11,790,855,000 | $11,431,840,000 | $11,095,472,000 | $9,997,162,000 |
| Other Intangible Assets | $4,450,522,000 | $4,092,742,000 | $3,729,659,000 | $2,630,374,000 |
| Current Assets | $6,681,876,000 | $8,077,766,000 | $8,530,120,000 | $6,491,633,000 |
| Other Current Assets | $209,261,000 | $211,392,000 | $391,058,000 | $232,348,000 |
| Hedging Assets Current | $125,455,000 | $295,000 | $10,303,000 | $29,305,000 |
| Inventory | $1,938,600,000 | $2,191,731,000 | $2,195,982,000 | $1,303,480,000 |
| Other Receivables | $5,413,000 | $4,795,000 | $5,951,000 | $2,769,000 |
| Taxes Receivable | $414,561,000 | $446,514,000 | $532,564,000 | $597,195,000 |
| Accounts Receivable | $2,249,259,000 | $2,642,146,000 | $2,531,789,000 | $2,039,474,000 |
| Allowance For Doubtful Accounts Receivable | $-30,965,000 | $-22,604,000 | $-21,026,000 | $-20,174,000 |
| Gross Accounts Receivable | $2,280,224,000 | $2,664,750,000 | $2,552,815,000 | $2,059,648,000 |
| Cash Cash Equivalents And Short Term Investments | $1,739,327,000 | $2,580,893,000 | $2,862,473,000 | $2,287,062,000 |
| Cash And Cash Equivalents | $1,739,327,000 | $2,580,893,000 | $2,862,473,000 | $2,287,062,000 |
| Cash Equivalents | $1,680,746,000 | $2,550,332,000 | $2,836,848,000 | $2,235,478,000 |
| Cash Financial | $58,581,000 | $30,561,000 | $25,625,000 | $51,584,000 |
| Debt | ||||
| Net Debt | $7,658,040,000 | $7,380,943,000 | $6,818,496,000 | $5,119,309,000 |
| Total Debt | $9,397,367,000 | $9,961,836,000 | $9,680,969,000 | $7,406,371,000 |
| Long Term Debt And Capital Lease Obligation | $7,988,364,000 | $7,820,840,000 | $7,382,212,000 | $6,803,883,000 |
| Long Term Debt | $7,988,364,000 | $7,820,840,000 | $7,382,212,000 | $6,803,883,000 |
| Current Debt And Capital Lease Obligation | $1,409,003,000 | $2,140,996,000 | $2,298,757,000 | $602,488,000 |
| Current Debt | $1,409,003,000 | $2,140,996,000 | $2,298,757,000 | $602,488,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $12,457,264,000 | $12,990,878,000 | $13,100,192,000 | $9,984,491,000 |
| Total Non Current Liabilities Net Minority Interest | $8,517,176,000 | $8,346,642,000 | $7,874,998,000 | $7,207,965,000 |
| Other Non Current Liabilities | $184,070,000 | $180,905,000 | $128,966,000 | - |
| Derivative Product Liabilities | $31,923,000 | $38,787,000 | $7,000 | $24,552,000 |
| Tradeand Other Payables Non Current | $32,415,000 | $2,805,000 | $4,179,000 | $112,043,000 |
| Non Current Deferred Taxes Liabilities | $136,824,000 | $175,752,000 | $206,378,000 | $73,993,000 |
| Current Liabilities | $3,940,088,000 | $4,644,236,000 | $5,225,194,000 | $2,776,526,000 |
| Other Current Liabilities | $409,688,000 | $418,705,000 | $431,239,000 | - |
| Payables | $2,113,061,000 | $2,067,550,000 | $2,443,607,000 | $2,126,354,000 |
| Other Payable | $367,523,000 | $442,286,000 | $378,933,000 | $560,937,000 |
| Dividends Payable | $648,559,000 | $696,966,000 | $677,773,000 | $704,808,000 |
| Total Tax Payable | $112,837,000 | $90,324,000 | $77,250,000 | $69,849,000 |
| Accounts Payable | $984,142,000 | $837,974,000 | $1,309,651,000 | $790,760,000 |
| Equity | ||||
| Common Stock Equity | $12,096,281,000 | $11,504,124,000 | $10,645,760,000 | $9,826,591,000 |
| Total Equity Gross Minority Interest | $12,101,819,000 | $11,517,873,000 | $10,655,441,000 | $9,833,471,000 |
| Stockholders Equity | $12,096,281,000 | $11,504,124,000 | $10,645,760,000 | $9,826,591,000 |
| Other Equity Interest | $-279,524,000 | $-278,927,000 | $-244,191,000 | $-181,839,000 |
| Long Term Equity Investment | $144,494,000 | $120,639,000 | $131,717,000 | $111,001,000 |
| Other | ||||
| Treasury Shares Number | $723,554 | $512,303 | $1,523,351 | $2,699,242 |
| Ordinary Shares Number | $632,697,269 | $632,908,520 | $631,897,472 | $630,721,581 |
| Share Issued | $633,420,823 | $633,420,823 | $633,420,823 | $633,420,823 |
| Tangible Book Value | $305,426,000 | $72,284,000 | $-449,712,000 | $-170,571,000 |
| Invested Capital | $21,493,648,000 | $21,465,960,000 | $20,326,729,000 | $17,232,962,000 |
| Working Capital | $2,741,788,000 | $3,433,530,000 | $3,304,926,000 | $3,715,107,000 |
| Total Capitalization | $20,084,645,000 | $19,324,964,000 | $18,027,972,000 | $16,630,474,000 |
| Minority Interest | $5,538,000 | $13,749,000 | $9,681,000 | $6,880,000 |
| Treasury Stock | $22,828,000 | $20,277,000 | $87,134,000 | $81,350,000 |
| Capital Stock | $9,705,886,000 | $4,478,126,000 | $4,478,126,000 | $4,478,126,000 |
| Common Stock | $9,705,886,000 | $4,478,126,000 | $4,478,126,000 | $4,478,126,000 |
| Long Term Provisions | $143,580,000 | $127,553,000 | $153,256,000 | $193,494,000 |
| Goodwill | $7,340,333,000 | $7,339,098,000 | $7,365,813,000 | $7,366,788,000 |
| Net PPE | $3,891,156,000 | $3,548,040,000 | $2,814,540,000 | $2,095,140,000 |
| Gross PPE | $3,891,156,000 | $3,548,040,000 | $2,814,540,000 | $2,095,140,000 |
| Construction In Progress | $693,233,000 | $719,678,000 | $554,243,000 | $330,376,000 |
| Other Properties | $80,882,000 | $78,022,000 | $57,437,000 | $120,114,000 |
| Machinery Furniture Equipment | $2,198,738,000 | $1,963,767,000 | $1,613,182,000 | $1,385,837,000 |
| Buildings And Improvements | $627,334,000 | $523,604,000 | $346,483,000 | $226,027,000 |
| Land And Improvements | $290,969,000 | $262,969,000 | $243,195,000 | $32,786,000 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-255,062,000 | $-183,056,000 | $-120,752,000 | $-100,609,000 |
| Finished Goods | $839,187,000 | $887,751,000 | $621,931,000 | $387,822,000 |
| Work In Process | $143,969,000 | $145,356,000 | $176,055,000 | $111,497,000 |
| Raw Materials | $1,210,506,000 | $1,341,680,000 | $1,518,748,000 | $904,770,000 |
| Investment Properties | - | $0 | $19,568,000 | $25,616,000 |
| Other Inventories | - | - | $164,149,000 | $127,389,000 |
| Accumulated Depreciation | - | - | - | $-839,134,000 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $1,767,332,000 | $1,583,280,000 | $529,337,000 | $560,249,000 |
| Operating Activities | ||||
| Operating Cash Flow | $2,539,599,000 | $2,395,993,000 | $2,038,793,000 | $1,399,131,000 |
| Investing Activities | ||||
| Capital Expenditure | $-772,267,000 | $-812,713,000 | $-1,509,456,000 | $-838,882,000 |
| Investing Cash Flow | $-592,438,000 | $-791,188,000 | $-1,742,337,000 | $-4,412,425,000 |
| Net Other Investing Changes | $1,739,000 | $-2,065,000 | $-139,000 | $-66,566,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-55,807,000 | $-88,453,000 | $-87,003,000 | $-128,666,000 |
| Issuance Of Capital Stock | $13,246,000 | $39,485,000 | $84,309,000 | $18,692,000 |
| Financing Cash Flow | $-2,788,727,000 | $-1,886,385,000 | $278,955,000 | $557,058,000 |
| Net Other Financing Charges | $-6,403,000 | $-67,789,000 | $-55,171,000 | - |
| Cash Dividends Paid | $-787,286,000 | $-759,885,000 | $-806,208,000 | $-745,936,000 |
| Common Stock Dividend Paid | $-787,286,000 | $-759,885,000 | $-806,208,000 | $-745,936,000 |
| Net Common Stock Issuance | $-42,561,000 | $-48,968,000 | $-2,694,000 | $-109,974,000 |
| Common Stock Issuance | $13,246,000 | $39,485,000 | $84,309,000 | $18,692,000 |
| Dividends Received Cfi | $4,657,000 | $3,478,000 | $2,533,000 | $0 |
| Other | ||||
| Repayment Of Debt | $-3,108,476,000 | $-1,925,175,000 | $-409,551,000 | $-519,687,000 |
| Issuance Of Debt | $2,351,000,000 | $2,221,882,000 | $2,419,817,000 | $2,241,072,000 |
| End Cash Position | $1,739,327,000 | $2,580,893,000 | $2,862,473,000 | $2,287,062,000 |
| Beginning Cash Position | $2,580,893,000 | $2,862,473,000 | $2,287,062,000 | $4,743,298,000 |
| Changes In Cash | $-841,566,000 | $-281,580,000 | $575,411,000 | $-2,456,236,000 |
| Interest Paid Cff | $-1,195,001,000 | $-1,306,450,000 | $-867,238,000 | $-308,417,000 |
| Common Stock Payments | $-55,807,000 | $-88,453,000 | $-87,003,000 | $-128,666,000 |
| Net Issuance Payments Of Debt | $-757,476,000 | $296,707,000 | $2,010,266,000 | $1,721,385,000 |
| Net Long Term Debt Issuance | $-757,476,000 | $296,707,000 | $2,010,266,000 | $1,721,385,000 |
| Long Term Debt Payments | $-3,108,476,000 | $-1,925,175,000 | $-409,551,000 | $-519,687,000 |
| Long Term Debt Issuance | $2,351,000,000 | $2,221,882,000 | $2,419,817,000 | $2,241,072,000 |
| Interest Received Cfi | $186,314,000 | $146,108,000 | $140,294,000 | $67,303,000 |
| Net Business Purchase And Sale | $-12,881,000 | $-125,996,000 | $-226,940,000 | $-3,675,545,000 |
| Purchase Of Business | $-12,881,000 | $-125,996,000 | $-226,940,000 | $-3,675,545,000 |
| Net Intangibles Purchase And Sale | $-342,875,000 | $-352,530,000 | $-993,908,000 | $-206,163,000 |
| Purchase Of Intangibles | $-342,875,000 | $-352,530,000 | $-993,908,000 | $-206,163,000 |
| Net PPE Purchase And Sale | $-429,392,000 | $-460,183,000 | $-515,548,000 | $-632,719,000 |
| Purchase Of PPE | $-429,392,000 | $-460,183,000 | $-515,548,000 | $-632,719,000 |
| Taxes Refund Paid | $-7,878,000 | $-4,132,000 | $-5,950,000 | $-7,046,000 |
| Interest Paid Cfo | $-55,528,000 | $33,248,000 | $45,262,000 | $-4,977,000 |
| Change In Working Capital | $696,237,000 | $-467,658,000 | $-726,522,000 | $-743,876,000 |
| Change In Other Current Liabilities | $-6,146,000 | $-86,620,000 | $-115,662,000 | $52,448,000 |
| Change In Other Current Assets | $-29,812,000 | $8,532,000 | $-15,037,000 | $2,929,000 |
| Change In Accrued Expense | $-28,590,000 | $8,499,000 | $91,066,000 | $45,758,000 |
| Change In Payable | $144,534,000 | $-550,099,000 | $537,592,000 | $75,396,000 |
| Change In Inventory | $80,122,000 | $-90,970,000 | $-961,655,000 | $-405,538,000 |
| Change In Receivables | $536,129,000 | $243,000,000 | $-262,826,000 | $-514,869,000 |
| Other Non Cash Items | $807,179,000 | $979,999,000 | $826,200,000 | $314,927,000 |
| Stock Based Compensation | $33,203,000 | $46,196,000 | $24,875,000 | $24,954,000 |
| Provisionand Write Offof Assets | $-222,230,000 | $-25,939,000 | $8,607,000 | $49,998,000 |
| Depreciation And Amortization | $281,055,000 | $238,312,000 | $169,101,000 | $133,686,000 |
| Depreciation | $281,055,000 | $238,312,000 | $169,101,000 | $133,686,000 |
| Net Foreign Currency Exchange Gain Loss | $33,533,000 | $28,337,000 | $45,416,000 | $8,745,000 |
| Gain Loss On Sale Of PPE | $957,000 | $43,665,000 | $61,146,000 | $420,834,000 |
| Net Income From Continuing Operations | $975,514,000 | $1,506,986,000 | $1,597,822,000 | $1,209,329,000 |
| Net Investment Purchase And Sale | - | $0 | $-148,629,000 | $101,265,000 |
| Purchase Of Investment | - | $0 | $-148,629,000 | - |
| Sale Of Investment | - | - | - | $101,265,000 |
| Gain Loss On Investment Securities | - | - | - | $423,957,000 |
Fetched: 2026-02-02